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Abstract
With the trend in molecular epidemiology towards both genome-wide association studies and complex model-
ling, the need for large sample sizes to detect small effects and to allow for the estimation of many parameters
within a model continues to increase. Unfortunately, most methods of association analysis have been restricted
to either a family-based or a case-control design, resulting in the lack of synthesis of data from multiple studies.
Transmission disequilibrium-type methods for detecting linkage disequilibrium from family data were developed
as an effective way of preventing the detection of association due to population stratification. Because these
methods condition on parental genotype, however, they have precluded the joint analysis of family and case-
control data, although methods for case-control data may not protect against population stratification and do
not allow for familial correlations. We present here an extension of a family-based association analysis method
for continuous traits that will simultaneously test for, and if necessary control for, population stratification. We
further extend this method to analyse binary traits (and therefore family and case-control data together) and
accurately to estimate genetic effects in the population, even when using an ascertained family sample. Finally,
we present the power of this binary extension for both family-only and joint family and case-control data, and
demonstrate the accuracy of the association parameter and variance components in an ascertained family sample.
Keywords: ascertainment correction, family-based association, linkage disequilibrium
Introduction
For much of the past three decades, linkage analysis
has been the primary tool for the initial exploration
of complex diseases believed to have an underlying
genetic aetiology and has resulted in many large
cohorts of family data with DNA samples available.
Unfortunately, however, the ability of linkage analysis
to localise potentially segregating susceptibility or
protective genotypes has been limited to, at best,
regions of 5–10 centimorgans (cM) in length and, at
worst, 20 cM in length.1 This limitation has led to a
rise in popularity of methods for detecting allelic (or
gametic) association in candidate genes, in candidate
linkage regions or genome-wide. This allelic associ-
ation, coupled with linkage, allows for much more
precise localisation of regions housing disease genes
because, if it is due to linkage disequilibrium (LD), it
will span a much shorter distance within the genome
than is usually found by linkage analysis. With this
rise in association studies, there has been a trend
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toward the collection of unrelated case-control
samples, often with the abandonment of large family
studies. Certainly, these samples are much easier to
obtain than are family samples, but they also have
certain limitations, even within the context of recent
genome-wide association successes.2,3 Further, allelic
association can be due to factors other than LD
(which we define as the combination of allelic associ-
ation and linkage) or pleiotropy (a marker allele itself
being involved in the aetiology of the disease).4
Population stratification, which exists when mul-
tiple strata within a given sample differ with respect
to either the underlying trait distribution or the
marker genotype distribution (and which leads to
spurious association when it occurs with respect to
both), is a commonly cited cause of false-positive
findings in case-control association studies (eg
Knowler et al.5) and the most likely cause in genetic
epidemiological studies. This threat of increased type
I error rate has led to the development of many
methods that guard against the effects of population
stratification. The first two general classes use
unlinked loci and can both be subsumed under the
term ‘genomic control’: (1) test for population strati-
fication using unlinked regions of the genome; (2)
allow for the population stratification, as estimated
from unlinked regions of the genome when per-
forming an analysis of allelic association. The third
general class guards against population stratification
by using non-transmitted alleles as controls (ie a
case-control design perfectly matched for ethnicity
by appropriately using family data). While these
methods are effective in controlling for population
stratification, they each have their limitations with
respect to power, efficiency and flexibility.
The limitations of genomic control methods6–8
are the requirement of having genotypes at many
loci unlinked to the disease allele. In the context of
a genome-wide association scan, the choice of the
best regions to use as a ‘control’ is difficult, as there
is no guarantee that the markers being used are
indeed unlinked to a disease gene. Applying this
method to a candidate gene study suffers from the
same limitation, but also requires significant
additional cost and labour to type enough (and
how many is enough?) additional loci.
Transmission disequilibrium tests (TDTs) — as
they were termed by Spielman et al.9 and are com-
monly referred to — comprise, in general, a
unique study design (rather than a single statistical
test) that protects against the effects of population
stratification by comparing the frequencies of alleles
(haplotypes or genotypes) transmitted from parents
to their affected children with the frequencies of
non-transmitted alleles to these same children.
These tests of allelic association condition on, at
least, parental genotypes and offspring disease phe-
notypes. Many TDT-type designs have been
suggested since first proposed by Rubinstein
et al.,10 including extensions for multiple siblings,
missing parents and extended pedigrees — to name
but a few (see Table S1). All of these extensions,
however, retain conditioning on part of the data
available and therefore share the following limit-
ations: (1) conditional tests are sensitive to sampling
strategy, leading to very low power under several
conditions;11 and (2) missing parental data, trans-
missions from homozygous parents — or from
heterozygous parents to heterozygous children —
are non-informative, which results in a dramatic
reduction of effective sample size and therefore of
power, particularly when analysing single nucleo-
tide polymorphism (SNP) data. This may also lead
to an increased type I error rate if care is not taken
to include the transmissions from two similarly het-
erozygous parents when the child is heterozy-
gous.12 Further, as for all tests of allelic association,
the power of TDT-type designs rapidly decreases if
the marker is not the disease locus and/or if the
marker and disease allele frequencies differ.13–15
Novel methodological approaches for the analysis
of LD in family data include a class of variance
component approaches and what are termed
family-based association tests (FBATs). Fulker first
proposed a test for both between-family association
(or, more appropriately, ‘among-family’, as we typi-
cally expect more than two families), which models
the phenotypic means given the marker locus gen-
otypes, and within-family association (linkage) by
using identity-by-descent status in modelling the
sib-pair variance–covariance structure.16 It was
shown that the within-family component provides
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an estimate of the additive genetic effect unaffected
by population stratification. Sham et al.17 extended
this method to incorporate larger sibships, domi-
nance variance and multi-allelic markers. It was
further extended to sibships with or without par-
ental genotypes, and to multi-generational pedigree
data by Abecasis et al.18 FBAT is a unified approach
to family-based tests of association that ‘compares
tests for association to their conditional distri-
butions given the minimal sufficient statistics under
the null hypothesis for the genetic model, sampling
plan and population admixture’,19 in two steps: (1)
building a test statistic that is sensitive to the
co-variation of the trait and marker; and (2) finding
the distribution of the test statistic under the null
hypothesis. Broadly speaking, the test statistic is the
‘covariance between a function of the genotype
and a function of the trait’,20 the dependent vari-
able being the offspring genotype. While the first
step gives great flexibility in the choice of test stat-
istic, the second is designed to ensure correct type
I error rates (ie validity), regardless of population
admixture, genetic model or ascertainment
scheme.21 These approaches are broad, in that they
can handle different genetic models, different
family structures (including extended pedigrees)
and disease phenotypes (qualitative or quantitative,
single or multiple). As with the original TDT,
however, only heterozygous parents are informative
in this framework; non-family data cannot be
included and, in the case of FBAT, even if one does
have a random sample, the effect size of the allele
of interest is not estimated. This can lead to a dra-
matic loss of effective sample size and therefore
potential power and/or precision when compared
with an unconditional method such as that pre-
sented here and demonstrated in our previous
work.22 Other methods more robust to these par-
ticular limitations have been recently proposed for
assessing quantitative traits in family-based
samples23 and binary traits in case-control samples,
including related individuals.24,25 Neither of these
methods, however, includes an ascertainment cor-
rection (central to pooling family and case-control
samples), nor do they estimate family or cluster
effects. Further, the former does not allow for the
inclusion of case-control data and the latter does
not allow for the inclusion of covariates.
Based on the limitations of the existing strategies
for testing LD, we present an alternative two-stage
family-based association test in which we combine
attributes of two existing methods, first to test
whether population stratification is present and
then appropriately test for and estimate the effect
of, LD of a marker to a continuous trait. We
further offer extensions of this method that can be
applied to binary traits and hence allow an analysis
of case-control data together with family data. We
illustrate the power of this method for various
sample sizes and structures, specifically for joint
family and population-based samples that cannot be
analysed by existing methods. We also extend this
method to allow for the accurate estimation of
association parameters and residual variance com-
ponents from ascertained family data, and demon-
strate, via simulation, that this method is effective
in controlling ascertainment bias.
Methods
Continuous traits
The framework on which our approach is built was
first described by George and Elston26 and Elston
et al.27 in the special context of a randomly selected
family sample with a measurable, quantitative trait
of interest. For any individual i, with continuous
trait (or, as we will later discuss, liability) yi, j
th cov-
ariate values cji and a genotype indicator zi, we can
construct a regression model of the form:
h yið Þ ¼ h aþ g1c1i þ g2c2i þ . . .þ gncni þ dzið Þ
þ pi þ fi þ f 0i þ mi þ si þ 1i; ð1Þ
in which the number of A1 alleles, along with other
covariates, is a predictor of phenotype. In this
model, zi is coded such that the allelic effect of sub-
stituting A2 for A1 is
1
2
d. The random components
include pi, a random polygenic effect, fi and f ’i,
random nuclear family effects, mi, a random marital
effect, si, a random sibship effect and 1i, a random
residual individual effect. In addition, the general-
ised power transformation (h),28 applied to both the
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trait and its predictors, when simultaneously esti-
mated under a model that assumes normality of the
residuals, helps assure both linearity and normality,
thus making the model robust to non-independence
(as can be the case in large pedigrees). There are
two random nuclear family effects fi and f
0
i in model
(1) because each individual is potentially a member
of two different nuclear families, one in which we
include the individual’s parents and siblings and one
in which we include the individual’s spouse and
children. All the random effects in the model are
assumed to be mutually independent and, after the
transformation, normally distributed with zero
means and variances sp
2, sf
2 ¼ sf ’2 , sm2 , ss2 and s12
such that: V[h(yi)] ¼ sp2 þ sf2 þ sf ’2 þ sm2 þ ss2 þ
s1
2 for families with more than two generations, and
V[h(yi)]¼sp2 þ sf2 þ sm2 þ ss2 þ s12 for families
with only two generations. It is important to note
that the total variance V[h(yi)] is made the same for
all individuals by adjusting the residual variance s1
2
separately for each person (see Elston et al.27 for
details). This model has recently been further
extended to allow for each person to have more
than two nuclear family effects, as can occur when
there are half-sibships in the data, and other kinds of
common environmental cluster effects.
As currently implemented in the S.A.G.E.
program ASSOC, the likelihood is maximised
numerically over all parameters, and standard errors
are determined by numerical double differentiation
of the log likelihood. Also, p-values, based on the
likelihood ratio or a Wald test, can be calculated for
the transformation parameters, any of the variance
components and any regression coefficients. They
are two-sided for all transformation parameters and
regression coefficients, and one-sided for all var-
iance components.
This method is meant to follow existing evi-
dence of linkage because it does not control for
population stratification. With the growing popu-
larity of genome-wide and candidate gene associ-
ation studies, however, there are likely to be many
instances in which linkage is not known a priori.
For this reason, we suggest — rather than auto-
matically resorting to cumbersome genomic
control methods or a less powerful TDT-type
design — using a two-stage procedure to (1) test
for a stratification effect and then (2) test for allelic
association. If there is no stratification, then the
association resulting from model (1) can be inter-
preted as LD effects. If there is stratification, then
one can use the same regression model framework
to perform a test like those mentioned above (TDT
and FBAT) that conditions on parental genotype.
To test for stratification, we use the same
regression model outlined above, but with the
addition of transmitted and non-transmitted allele
indicators (x1i and x2i) defined as:
x1i ¼
1 if A is transmitted from an informative mating
0 otherwise

x2i ¼
1
if A is not transmitted from an
informative mating
0 otherwise:
8><
>:
Thus, the regression equation (3) for the trait value
yi is now defined as
hðyiÞ ¼ hðaþ b1x1i þ b2x2i þ g1c1i þ g2c2i
þ . . .þ gncni þ dziÞ þ hi; ð2Þ
where hi is the random effect comprising all of the
familial, sibling, marital, polygenic and individual
specific errors outlined above. George et al.29 gave
details of how the indicator variable x1i is constructed
to form a TDT-type test by substituting it for zi in
regression model (1). We point out that, because it
includes components of a TDT-type test, it requires
family data. The variable x2i is formed analogously
for the other allele of an SNP. In the case of a multi-
allelic marker, all the other alleles can be pooled into
a single allele for this purpose. To test for a stratifica-
tion effect, we first test the null hypothesis that the
genotypic effect is half the difference of the trans-
mitted allele effects; that is, b2 – b1 ¼ 12 d. If we do
not reject this null hypothesis at some liberal signifi-
cance level such as p ¼ 0.2, we infer that there is no
evidence of stratification, set b2 ¼ b1 ¼ 0 and esti-
mate the allele A1 effect by
1
2
d. If there is any
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evidence of stratification, we set d ¼ 0 and estimate
the allele A1 effect by b2 – b1. Thus, once either
b2 ¼ b1 or d is set to 0, as appropriate, we return to
a framework in which we simultaneously estimate the
effect of allele A1, the residual variance components
and one or more transformation parameters. We can
use asymptotic results to obtain confidence intervals
for all parameter estimates in the usual way, and the
method can be extended to estimate genotype effects
rather than allele effects. While other approaches like
the principal component approach proposed by Zhu
et al.30 work well within this regression framework
and are potentially more informative when many
SNPs are available, this new approach is a viable
option, even if only one or a few SNPs are typed (ie
in the case of a candidate gene study).
Extension to binary traits
The generalised modulus power transformation
mentioned above is fairly effective in inducing
approximate normality, but does, of course, assume
a continuous trait distribution. In many cases, con-
tinuous traits are not available to characterise
complex diseases and only the presence or absence
of disease is available. Therefore, we propose the
following algorithmic extension of Zhu et al.31 Let
mi0 ¼ 0:9; if y

i ¼ 1
0:1; if yi ¼ 0

; ð3Þ
where yi
* is the binary trait of interest, 1 represents
affected individuals and 0 represents unaffected, and
mi0 represents an initial estimate of E(yi
*). Our aim
here is to define a new trait yi that, if mi were its
expected value, would be approximately normally
distributed with mean 0 and variance 1. We use
the values of yi defined by equations (2) and (3) as
the dependent variable in a simple generalised
linear regression model of the form
log it½EðyiÞ ¼ aþ b1x1i þ b2x2i þ g1c1i þ g2c2i
þ . . .þ gncni þ dzi ð4Þ
We have shown that the iterative maximisation pro-
cedure currently implemented in our software
(ASSOC) is quite robust to these initial estimates,
regardless of family size or misspecified analysis
model.32 We do note, however, that the ease of maxi-
misation and the accuracy of estimates depend on
both the sample size and the number of parameters
estimated. In general, we recommend at least 20
observations per parameter estimated to ensure accu-
racy (which can be assessed based on standard errors
we provide).
Because the likelihood that is maximised by this
process is perhaps not a true likelihood (it is a
pseudo-likelihood, in that the estimates of the var-
iance components may be based on incorrect
model assumptions), the variance–covariance
matrix of the estimators obtained by double differ-
entiation of the likelihood may not equal the true
variance matrix, even asymptotically. We may
therefore estimate the variance–covariance matrix
using the robust sandwich estimator,33
Vsand ¼ H^11 H^2H^11 ; ð5Þ
where H^1 is the estimated Fisher information matrix,
which we need not assume is correctly specified,
and H^2 is the estimated outer product gradient
expressed as
H^2 ¼
X
k
D^0k
X^1
k
½ðyk  mkÞðyk  mkÞ0
X^1
k
D^0k
ð6Þ
where, for the the kth pedigree,
P^
k is a diagonal
matrix with elements mik(12mik), yk is the vector of
trait values for the kth pedigree, mk is the vector of
means specific to the kth pedigree and Dk, with trans-
pose D0k, is the matrix of first order partial derivatives
of mk with respect to b obtained assuming that the
covariates are fixed:
Dk
Nkxp
¼
@m1
@b1
@m1
@b2
   @m1
@bp
@m2
@b1
@m2
@b2
   @m2
@bp
..
. ..
. . .
. ..
.
@mNk1
@b1
@mNk1
@b2
   @mNk1
@bp
2
66666666664
3
77777777775
: ð7Þ
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In matrix (7), Nk is the number of persons in the k
th
pedigree, p is the total number of regression coeffi-
cients in equation (4), including the intercept, and bj
represents any one of them.
Combining case-control and family data
One of the benefits of the regression framework
outlined above is the flexibility to include families
of any size or structure. This is vital, given, as men-
tioned above, that the magnitude of the effects
associated with any given gene for a common
complex disease is likely to be small. Certainly, pro-
vided we are only interested in hypothesis testing
(we will discuss parameter estimation later),
unmatched case-control data can be easily included
as single person pedigrees with only an individual-
specific variance. In this framework, however,
matched case-control data can also be included by
simply specifying the matched pairs as members of
the same cluster (a cluster, of course, being a
special case of a pedigree). We include in the
model a cluster-specific variance component sc
2,
such that V[logit(yi)]¼sc2þs12, and then adjust the
residual variance s1
2 so as to keep the total variance
the same for all individuals. This approach does not
limit the case-control cluster size or composition,
as does conditional logistic regression.
Correcting for ascertainment
The underlying assumption of the method outlined
above is that the sampling units (families, individ-
uals, case-control clusters) represent a random
sample from the same population. This is often not
the case — particularly when families were sampled
for a linkage study — and cannot be the case for
case-control samples. The sample association and
variance component estimates are thus not repre-
sentative of the population values. We therefore
present an ascertainment correction specifically for
family data (and briefly address an extension to
case-control data in the discussion).
Let the proband sampling frame (PSF) comprise
those individuals who, regardless of phenotype,
could have allowed the family to be ascertained by
reason of being in the catchment area (the area
from which the sample was collected). Then, let
the ascertainment corrected natural log (ln) likeli-
hood be:
lnLðPÞ ¼ lnLðPAllÞ  lnLðPPSFÞ ð8Þ
where L(P) is the final likelihood, L(PAll) is the like-
lihood for the whole sample on the assumption of
random sampling of families and L(PPSF) is the like-
lihood for the family members in the PSF, similarly
on the assumption of random sampling. (For single
ascertainment, only the probands are included in
the PSF). Maximising this likelihood (8) leads to
consistent estimators of all the parameters.34
Power calculations for family data
To assess the power and type I error of our associ-
ation analysis method as extended to binary traits, as
well as to verify the accuracy of both the association
parameters and the residual variance components
for ascertained data, we simulated 2,000 replicates of
samples of 1,000 individuals comprising either 200
nuclear families (two founders, three offspring) or
125 extended pedigrees (three founders, one of
whom is a ‘marry-in’: three generations; one sibship
of size 3 in generation 2; one sibship of size 2 in
generation 3). A continuous liability was created
according to the following linear model:
yi ¼ ai þ gpi þ
Xk
j¼1
djd ji þ 1ei; ð9Þ
where i represents the ith individual; ai is the genoty-
pic effect assigned based on an individual’s major
genotype defined as:
a ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
h2ls
2q 1  qð Þ
s
; ð10Þ
where q is the allele frequency and hls
2 is locus-
specific heritability, which we varied to have values
0 (the null hypothesis), 0.0025, 0.0125, 0.025,
0.0375, 0.05 and 0.0625; g is the coefficient (set to
0.25) of the polygenic effect (or ‘polygenotype’) pi,
generated from a N(0,1) distribution for founders
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and for non-founders derived as 1
2
(polygenotype of
the mother þ polygenotype of the father) þ a ran-
domly generated value from a N(0, 1
2
); dj is the coef-
ficient for the jth environmental effect which, in our
examples were familial (F), sibling (S) and/or
marital (M) (set to 0 when not included in the
model and to 0.25 otherwise); dji is the environ-
mental factor value assigned to all individuals within
the same familial cluster and distributed N(0,1)
across such clusters, 1 (set to 0.5) is the coefficient
of the random effect; and ei is generated separately
for each individual from a N(0,1) distribution. The
liability yi was then transformed to a binary pheno-
type. First, a standardised liability was created as:
zi ¼ ðyi  yÞﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1=n 1Pn
i¼1
ðyi  yÞ2
r ; ð11Þ
where yi is the continuous liability created as
defined above and is a mixture of three normal dis-
tributions with means equal to the genotypic effects
of the three genotypes and a common variance
(specific to the variance component model as
shown in Table 1), y is the sample mean, n is the
total sample size, and 1=n 1Pn
i¼1
ðyi  yÞ2 is the
sample variance. This transformation resulted in
three distributions for the A1A1, A1A2, and A2A2
genotypes, with means (a 2 (q2a2(12 q)2a)), (02
(q2a 2(12 q)2a)), and (2a 2 (q2a 2(12 q)2a)),
respectively, the whole mixture distribution having a
variance of 1. Then, an individual was classified as
affected if zi . x, unaffected otherwise. For all
simulations, x was fixed at 1.28, corresponding to a
disease prevalence of approximately 0.1. Thus, A1 is
the ‘risk’ allele.
Creation of a random sample was achieved by
simply collecting individuals (and thus their entire
pedigree) from the simulated population in the
order in which they were encountered until the
desired sample size (1,000 individuals) was met. All
replicates were analysed using both the simulated
correlation model and an ‘incorrect’ correlation
model. For example, if data were simulated to have
both a familial and polygenic effect, they were ana-
lysed under a model (denoted as FP) including
both effects and one (denoted P) that included
only a polygenic effect. Names for all the models
investigated are enumerated in Table 1.
Type I error was calculated as the number of
replicates simulated under the null hypothesis
meeting a recommended cut-off point for genome-
wide association studies by the Wellcome Trust of
a ¼ 510–7.35 Power was calculated as the
number of replicates meeting the same criterion
but simulated under the alternate hypothesis.
Sample size estimation for joint family and
case-control data
In addition to the simulations outlined above, in
order to demonstrate the usefulness of this method
for the joint analysis of family and population or
Table 1. Total variance of the non-major gene component of the continuous liability underlying the binary trait and the proportion of
that variance represented by each variance component for each model
Simulated proportion of variance for each variance component
Model
name
Total
variance
Polygenic Familial Sibling Marital Random
P 0.3125 0.200 - - - - - - - - - - - - - - - - - - 0.800
FP 0.3750 0.167 0.167 - - - - - - - - - - - - 0.667
SP 0.3750 0.167 - - - - - - 0.167 - - - - - - 0.667
MP 0.3750 0.167 - - - - - - - - - - - - 0.167 0.667
SMP 0.4375 0.143 - - - - - - 0.143 0.143 0.571
F ¼ familial effect; M ¼ marital effect; P ¼ polygenic effect; S ¼ sibling effect.
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case-control data, we analytically estimated, for a
combination of unrelated individuals (50 per cent
cases, 50 per cent controls), nuclear families and/or
extended pedigrees, the number of individuals
required to detect a given effect size at a fixed type
I error rate and power.
For these calculations, we classified families
according to the number of founders and non-
founders (where unrelated individuals were simply
one-founder pedigrees). Suppose there are ni
families of the ith type, each with nfi founders and
nnfi non-founders. Let yjm be the trait value under-
lying liability for the mth individual in the jth family
with polymorphic marker value gji, and let ajm be a
row vector whose elements are the intercept and
effect of other covariates. Let b be the regression
coefficient on the polymorphic marker and define
Zjm¼yjm2ajm1¼b(gjm2E(gjm)), where 1 is a
column vector of unities. The three genotypes of
the marker are assumed to have the values
(22,1,1), (21,21,2) and (21, 0, 1) for dominant,
recessive and additive modes of inheritance,
respectively. Then, letting Zi
0¼(zf1 . . . zfni, znf1 . . .
znfnfi ), S
1
i ¼ the inverse of the variance–covariance
matrix for the ith-type family and assuming
multivariate normality, the log likelihood for
the ith-type family is Li ¼ const21
2
(Zi2b(Gi2
E(Gi)))
0S1i (Zi2b(Gi2E(Gi))), giving the
maximum likelihood estimator
b^ ¼
P
i
niðGiEðGiÞÞ0S1i ZiP
i
niðGiEðGiÞÞ0S1i ðGiEðGiÞÞ
; with
varðb^ Þ ¼
P
i
nivarððGiEðGiÞÞ0S1i ZiÞ
ðP
i
niðGiEðGiÞÞ0S1i ðGiEðGiÞÞ2
¼
P
i
niðGiEðGiÞÞ0S1i ðGiEðGiÞÞ
ðP
i
niðGiEðGiÞÞ0S1i ðGiEðGiÞÞÞ2
¼ 1P
i
niðGiEðGiÞÞ0S1i ðGiEðGiÞÞ
:
This is an extension of Nick et al.,36 who gave
approximate results for exactly two founders and a
dominant mode of inheritance, and assumes the
quantitative trait locus and marker variants are in
perfect LD. We derived var(bˆ) more generally for nfi
founders, for both additive and dominant inheri-
tance, as well as for relative pair specific correlations.
We also allowed for incomplete LD by applying a 1/
(0.8)-fold factor (equivalent to r2 ¼ 0.8, D’  0.9).
For these calculations, we made some simplifying
but conservative assumptions. First, we assumed that
founder pairs have a correlation of 0 and that parent–
offspring correlations (rpo) and sib–sib correlations
(rss) correspond to a residual heritability of 2 rpo ¼ 2
rss and that grandparent–grandchild pairs have a
residual correlation of rgg corresponding to a residual
heritability of 4 rgg. We further assumed, for simpli-
city, that all persons with the same genotype at the
disease locus have the same disease risk and that LD
between the locus and the closest SNP, assuming the
same allele frequencies at the two loci, is given by r2.
Finally, we imposed the type I error recommended
for genome-wide association studies by the
Wellcome Trust of a ¼ 51027,35 and assumed a
fixed power equivalent to a sample of 500 cases and
500 controls (0.92 for an additive model and 0.86 for
a dominant model), and a locus-specific heritability
of hls
2 — see equation (11) — of 0.05. We did this for
samples of nuclear families only, extended pedigrees
only and mixtures of both, for various sample sizes,
and then, demonstrated the approximate linearity of
the trend in sample size needed to detect the same
effect given a fixed power and type I error.
Accuracy of association and variance
component estimates
In addition to generating random family samples
(RAND), we also generated a sample of singly ascer-
tained families (ASC) by assigning each family a
probability of entering the sample based on the
number of affected members in the family: P(family
enters sample)¼Na/N, where Na is the number of
affected members in the family and N is the number
of family members. Each simulation output file was
parsed and, if a family had an affected member, the
above probability was calculated and, based on the
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appropriate Bernoulli distribution, the family was
either ascertained or not until the desired sample size
was met.
The accuracy of the locus-specific association
parameter (b) and the polygenic and familial var-
iance components were assessed after the appropri-
ate analysis (ie with ascertainment correction if ASC
and without if RAND) using the empirically found
mean square error (MSE) averaged over 100 repli-
cates, each comprising 1,000 individuals from either
200 nuclear families or 125 extended pedigrees. In
all cases, the root mean square error (rMSE) com-
pared with the simulated value (Tables 2–4) is
reported. As mentioned, the accuracy of estimates
in ascertained case-control samples was not
addressed in this study, but is discussed below.
Results
Type I error and power in family data
Under both additive and dominant models, the
association method we present for detecting dialle-
lic trait loci has stable type I error rates of less than
0.05 (mean ¼ 0.0452) for the RAND sample of
both the nuclear families and extended pedigrees.
The ASC sample had slightly higher type I error
rates for the nuclear family sample (0.0523) but not
for the extended pedigrees (0.0427). The power
reached 100 per cent at a total heritability of 0.25
(hls
2¼0.0625) for both the additive and dominant
models in both the nuclear family sample and the
extended pedigrees, and there was virtually no
power to detect a heritability of 0.01. The power
curves for the RAND and ASC samples were vir-
tually identical, so for the sake of space only the
ASC curves are presented. The nuclear family
sample (200 families, 1,000 individuals), out-
performed the extended pedigree sample (125
families, 1,000 individuals) under both models.
Further, there was a steep decline in power
between heritabilities of 0.15 (hls
2 ¼ 0.0375) and
0.10 (hls
2 ¼ 0.025) (Figure 1).
Sample size estimation in joint family and
case-control data
To demonstrate the usefulness of family data in
association analysis, as well as the usefulness of
combining samples from both linkage (family-
based) and association (typically case-control)
Table 2. Accuracy of the association parameter as ln odds of
being affected given two copies of the disease allele versus one
copy for a sample size of 1,000 individuals
Nuclear Extended
Model* RAND ASC RAND ASC
FP–FP Est 2.529 2.479 2.511 2.561
rMSE 0.1709 0.1210 0.1530 0.2030
FP–P Est 2.537 2.509 2.517 2.524
rMSE 0.1789 0.1510 0.1591 0.1661
P–FP Est 2.780 2.655 2.763 2.722
rMSE 0.1775 0.0529 0.1603 0.1196
P–P Est 2.780 2.648 2.768 2.724
rMSE 0.1775 0.0458 0.1655 0.1212
*Model indicates the variance components that were simulated followed by those
included in the analysis model (F ¼ familial and P ¼ polygenic); Est is the average
estimate across all replicates of that model; rMSE is the square root of the mean
square error; ASC represents the analysis of an ascertained sample using
ascertainment correction and RAND represents the analysis of a random sample
without any such correction.
Table 3. Accuracy of the association parameter as ln odds of
being affected given two copies of the disease allele versus no
copies for a sample size of 1,000 individuals
Nuclear Extended
Model* RAND ASC RAND ASC
FP–FP Est 5.058 4.958 5.022 5.122
rMSE 0.2936 0.3936 0.3295 0.2296
FP–P Est 5.074 5.018 5.034 5.048
rMSE 0.2777 0.3336 0.3176 0.3036
P–FP Est 5.560 5.310 5.526 5.444
rMSE 0.1010 0.5696 0.3536 0.4357
P–P Est 5.560 5.296 5.536 5.448
rMSE 0.3195 0.5836 0.3437 0.4316
*Model indicates the variance components that were simulated followed by those
included in the analysis model (F ¼ familial and P ¼ polygenic); Est is the average
estimate across all replicates of that model; rMSE is the square root of the mean
square error; ASC represents the analysis of an ascertained sample using
ascertainment correction and RAND represents the analysis of a random sample
without any such correction.
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studies, we evaluated the number of unrelated indi-
viduals that need to be added to an existing family
sample to be able to detect the same effect size as
in a population-based sample of 1,000 unrelated
cases and 1,000 controls. Beginning with a collec-
tion of 125 extended pedigrees or 200 nuclear
families (samples that are quite prevalent), one can
decrease the number of unrelated samples needed
to detect a given effect size (hls
2 ¼ 0.05) by at
minimum close to 40 per cent and at maximum
more than 50 per cent (Figure 2).
Note that the equivalence of samples is shown,
assuming (1) a common minor allele frequency
(q ¼ 0.5), for which the family data are not as
informative as are the case-control data, and (2) an
allele frequency under which the family sample is
fairly informative (q ¼ 0.1). As expected, the
nuclear family sample (assuming an additive model
Table 4. Accuracy of variance components as proportions of the total variance, N¼1,000
Nuclear Extended
Parameter Model RAND ASC RAND ASC
Marital MP–MP Est 0.079 0068 0.0775 0.0696
rMSE 0.0877 0.0990 0.0894 0.0693
SMP–SMP Est 0.1743 0.0636 0.1291 0.0555
rMSE 0.0316 0.0781 0.0141 0.0866
Sibling SP-SP Est 0.0574 0.0669 0.0549 0.0713
rMSE 0.1095 0.1000 0.1122 0.0959
SMP–SMP Est 0.0549 0.0554 0.057 0.0579
rMSE 0.0883 0.1118 0.0860 0.1090
Polygenic FP–FP Est 0.0896 0.0604 0.1711 0.1388
rMSE 0.0775 0.1068 0.0000 0.0283
MP–MP Est 0.0741 0.0655 0.0775 0.0643
rMSE 0.0927 0.1015 0.0894 0.1030
P–P Est 0.063 0.0805 0.0602 0.0755
rMSE 0.1039 0.1196 0.1068 0.1249
SMP–SMP Est 0.2169 0.0617 0.1759 0.0559
rMSE 0.0742 0.0800 0.0332 0.0860
SP–SP Est 0.0962 0.0723 0.0782 0.0603
rMSE 0.0707 0.0949 0.0889 0.1068
Familial FP–FP Est 0.1133 0.0122 0.033 0.0139
rMSE 0.0539 0.3521 0.1342 0.1530
P-FP Est 0.0198 0.0032 0.048 0.0102
rMSE 0.0200 0.0032 0.0480 0.0100
*Model indicates the variance components that were simulated followed by those included in the analysis model (F ¼ familial, M ¼ marital, S ¼ sibling and P ¼ polygenic); Est is
the average estimate across all replicates of that model; rMSE is the square root of the mean square error; ASC represents the analysis of an ascertained sample using
ascertainment correction and RAND represents the analysis of a random sample without any such correction.
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with q ¼ 0.5) requires the fewest additional unre-
lated individuals to detect a given effect, and the
extended pedigree sample (assuming a dominant
model with q ¼ 0.5) requires the most additional
unrelated individuals. The extended pedigree
sample, under a dominant model with q ¼ 0.5 or
0.1, performed similarly, as did the nuclear family
sample under a dominant model with q ¼ 0.5 or
0.1. The extended pedigree and nuclear family
samples (assuming an additive model) require
approximately the same number of additional unre-
lated persons to detect the given effect size.
Figure 1. Power to detect association by both total and locus-specific heritability for nuclear families (nuc fam) under an additive
model (No Dom) and a model with 50 per cent additive and 50 per cent dominance variance (Add ¼ Dom).
Figure 2. Number of unrelated case-control samples needed, in addition to a fixed sample of either nuclear or extended pedigrees,
to achieve a power of 92 per cent under an additive model (No Dom) and 86 per cent under a model with 50 per cent additive and 50
per cent dominance variance (Add ¼ Dom). Values were generated for fixed sample sizes of both nuclear families and extended
pedigrees, as well as for allele frequencies of both 0.5 and 0.1.
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In addition to providing the number of
additional individuals necessary to detect a fixed
effect size given a sample of nuclear or extended
pedigrees, we further provide this information
given a sample comprising varying proportions of
nuclear and extended pedigrees. We found that, for
the additive and dominant models, regardless of the
allele frequency, the samples that contained 30 per
cent extended pedigrees and 70 per cent nuclear
families (30:70) required the fewest additional unre-
lated individuals (of the three mixtures examined)
to attain the same power. For the model in which
dominance and additive variance were equal
(Add ¼ Dom) with allele frequency 0.5, the sample
with equal frequency of nuclear and extended pedi-
grees (50:50) and the sample that is 70 per cent
extended and 30 per cent nuclear (70:30) require
similar sample sizes except in the extreme cases
where there are very few to no unrelated individ-
uals (Figure 3). The results for the Add ¼ Dom
model with q ¼ 0.1 are similar to those for the
model with q ¼ 0.5, except that the divergence of
the 50:50 and 70:30 samples is not as large as in
the previous case (Figure 4). The additive model
indicates the least difference in the three sample
types (Figure 5); for example, a sample of 140
nuclear families and 38 extended pedigrees requires
500 additional individuals to achieve the same
power and type I error as 100 nuclear families, 63
extended pedigrees and 625 additional unrelated
persons.
Estimation using family samples
Accuracy of the association parameter
The estimates of the association parameter
(expressed as the ln odds of two copies of the
disease allele versus one copy) were, on average,
2.615 for the nuclear family sample and 2.636 for
the extended family sample — not too dissimilar to
the simulated value of 2.48. The RAND and ASC
samples had similar averages of 2.648 and 2.603,
respectively. Note that we purposely generated the
data under a (probit) model different from the
(logit) model used to analyse the data, to illustrate
the robustness of the analysis model, and that the
accuracy of the ascertainment correction is seen in
the small difference in parameter estimates between
the RAND and ASC samples. The average estimate
for the ascertained extended families (2.633) was
overestimated by a factor of 1.06, a slightly larger
deviation from the simulated value than seen in the
Figure 3. Number of unrelated case-control samples needed, in addition to a fixed, mixed sample of nuclear and extended pedigrees,
to achieve a power of 86 per cent under a model with 50 per cent additive and 50 per cent dominance variance (Add ¼ Dom),
assuming an allele frequency of 0.5. Values were generated for samples that comprised 30 per cent nuclear families and 70 per cent
extended pedigrees, 50 per cent and 50 per cent, and 30 per cent and 70 per cent, respectively.
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nuclear family samples, which had an average of
2.573 — only 1.03 times the simulated value (and
the closest to it). The rMSE averaged over all
models was 0.210 and all estimates were within a
factor of 1.15 of the simulated value (Table 2).
Results were similar for estimates comparing the
odds of two disease susceptibility alleles to no sus-
ceptibility alleles, on average 5.251 — again, not
too dissimilar to the simulated value of 5.616. The
RAND samples had an average of 5.296 and the
Figure 4. Number of unrelated case-control samples needed, in addition to a fixed, mixed sample of nuclear and extended pedigrees,
to achieve a power of 86 per cent under a model with 50 per cent additive and 50 per cent dominance variance (Add ¼ Dom),
assuming an allele frequency of 0.1. Values were generated for samples that comprised 30 per cent nuclear families and 70 per cent
extended pedigrees, 50 per cent and 50 per cent, and 30 per cent and 70 per cent, respectively.
Figure 5. Number of unrelated case-control samples needed, in addition to a fixed, mixed sample of nuclear and extended pedigrees,
to achieve a power of 92 per cent under as additive model (No Dom), assuming an allele frequency of 0.1. Values were generated for
samples that comprised 30 per cent nuclear families and 70 per cent extended pedigrees, 50 per cent and 50 per cent, and 30 per cent
and 70 per cent, respectively.
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ASC samples almost the same (5.206). Nuclear
(NUC) families had the estimate 5.230 and
extended families 5.273. In these cases, the random
nuclear family samples were the closest to the simu-
lated value. The average rMSE was 0.351 and all
estimates were within a factor of 0.88 of the simu-
lated value (Table 3). Notice that for these com-
parisons the effect was always under- rather than
overestimated, whereas in the previous comparisons
they were overestimates.
Accuracy of the variance components
Overall, the rMSEs were, as might be expected,
smaller for the RAND samples than for the ASC
samples. When comparing the estimated values
with the simulated proportions of variance
(Table 4), the estimates from the RAND and ASC
samples yielded good estimates of the true simulated
population values for the polygenic and familial
components, but the sibling and marital com-
ponents were often over- or underestimated in the
ASC sample, depending on both model and family
structure. Specifically, sibling (S) and marital (M)
components were consistently underestimated in the
SMP–SMP scenarios and overestimated in all other
scenarios.
The accuracy of the variance component esti-
mates were affected by the sampling scheme, as
expected. The RAND samples resulted in estimates
closest to the simulated population values, but ASC
samples yielded estimates reasonably reflective of
the population values as well.
Discussion
The prediction of the future of genetic studies of
complex disease is ever changing, but what remains
true is that we must have methods of analysis that
are both powerful and flexible. Whether searching
for common genes with small effect or rare genes
with large effect, we shall need large samples that
are likely to come only from combining family,
population-based and case-control data and we
must have methods that analyse these combinations.
In fact, the use of family samples was recently high-
lighted by Visscher et al.,2 showing that including
related individuals results in only a small loss of
power but large gains in terms of quality control,
flexibility of tests to be performed and ability to
control for population stratification. Our results
support these assertions and we further recommend
that association methods must account for environ-
mental covariates (which are certain to play a role
in complex diseases) and must not be restricted by,
but rather be effective in controlling for, population
stratification. These tools will be powerful in aiding
both genome-wide association and candidate gene
studies.
We have present here a method to test and estimate
the association between an allele or genotype and a
continuous or binary trait, as well as approaches to
combining family and case-control data that are
powerful as well as robust to ascertainment. We also
present a two-stage procedure to determine the need
for a test that is robust to stratification. A purist
would argue that a two-stage approach could affect
type I error rate. The important thing to note,
however, is that this decision should be made on the
basis of the significance, not the magnitude, of
the difference in the two estimates of marker effect,
b2 – b1 versus
1
2
d, because a study whose sample
size is powered to detect a small effect will auto-
matically be powered to detect the small biases that
stratification could induce.
We further present a method for correcting for
ascertainment and accurately estimating association
parameters, as well as variance components, even in
ascertained family data. Two things should be
pointed out, however. First, we examined only
single ascertainment, when a more complex
scheme is used to collect families such that most of
the sample is in the PSF and/or the PSF is unde-
fined, the estimates for the association parameter
and the variance components will reflect only the
effect in the sample. Note, however, that the test
for association is still valid and it is only the par-
ameter estimates that are affected. Secondly, when
combining data from a case-control sample and an
ascertained family sample, for the parameter esti-
mates from this method to be reflective of the
population from which the samples were drawn,
certain assumptions must be met: (1) the cases in
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the population-based data should have been pheno-
typed in a manner similar to the cases in the family
data; (2) there must be appropriate correction for
ascertainment; and (3) the non-cases or ‘controls’,
although matched, should apart from this also be a
random sample — if they are a completely random
sample from the same population, it is possible to
estimate a relative risk, while if they are a random
sample of those showing absence of the phenotype
of interest, only an odds ratio can be estimated. If
the phenotype is sufficiently rare such that choos-
ing controls based on absence of the trait of interest
is essentially the same as random sampling, then the
relative risk and odds ratio will be essentially the
same. Because this is not the case for common
complex diseases, we suggest and will investigate
further in future studies, two other ways of com-
bining case-control and family data for accurate
estimation: (1) express the likelihood for the case-
control data in terms of odds ratios, which are
functions of the parameters in the pedigree likeli-
hood, and constrain the maximum likelihood for
them such that the marginal probability of disease,
given a set of regressors, is finite;37 and (2) multiply
the likelihood by a factor that summarises any
information we have about the prevalence of
disease independent of the sample data. This factor
would be expressed as mR(12m)N–R, where m is the
prevalence of the disease — expressed as a function
of the parameters in the full likelihood at particular
values of the covariates in the model — and R
reflects our external information about the number
of affected persons in a population of size N. For
example, if we have an estimate of m, mˆ and its stan-
dard error (s.e.), we can estimate reasonable values
for N and R by noting s:e: ¼ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃm^ð1  m^Þ=Np , and
hence N ¼ m^ð1  m^Þ=ðs:e:Þ2 and R ¼ Nmˆ. It is
known that constraining likelihood maximisation so
that the estimated disease prevalence is equal to its
true prevalence can be equivalent to a correction for
single ascertainment.38 These two options offer
simple solutions for ‘non-traditional’ samples and
will be examined in future work.
The general method described in this paper,
which is currently being implemented in the
program package S.A.G.E., is more flexible than
other TDT-type methods and more efficient (in
the practical sense) than genomic control methods.
Further, we have shown the power of this method
for binary traits in various types of family,
population-based and combined samples at a con-
stant type I error rate and, while we concede that a
population-based sample could sometimes detect a
smaller effect size than the respective family-based
samples, as mentioned earlier, these scenarios
assume the same degree of heterogeneity and spora-
dic cases in all samples after correction for ascer-
tainment. We know that this is not likely to be the
case, as family samples are designed to decrease
greatly the number of sporadic cases and, at least to
some extent, reduce the amount of heterogeneity
in the sample in a manner that makes appropriate
ascertainment correction difficult. Further, for
most complex phenotypes, family samples of at
least the size examined here (and usually much
larger) already exist and, as shown in Figures 2 and
3, can drastically reduce the number of population-
based samples needed to detect even very small
effects. Other benefits of family data, such as
increased ability to assess the effects of shared
environment and parent-of-origin effects, to detect
errors and many others are beyond the scope of this
paper, but must also be considered. Finally, while
having to correct for ascertainment is one of the
reasons often cited for using population-based
versus family data, we have demonstrated that, in
principle, our method can be used to estimate
fairly accurately the effect size of a given allele of
interest for a given population, even if using an
ascertained sample. For situations where most of
the sample is in the PSF (and hence likelihood (8)
contains little information), or the PSF is ill-
defined, we suggest constraining the likelihood to
give an accurate estimate of the disease prevalence.
Future investigation will determine the accuracy of
estimates obtained in this manner.
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Table S1. Summary of TDT-type methods and their respective features
Incorporation of:
Method/
Reference
Missing
parents
Multiple
alleles
Parental
phenotypes
Quantitative
traits
Extended
pedigrees
Different
family
structures
Multiple
markers
Covariates
Curtis (1997)S1 * *
S-TDT (Spielman
and Ewens, 1998)S2
* * *
DAT (Boehnke and
Langefeld, 1998)S3
* *
SDT (Horvath and
Laird, 1998)S4
* * *
NFS (Whittemore
and Tu, 2000)S5
* * * * *
TRANSMIT
(Clayton, 1999)S6
* * * *
RC-TDT (Knapp,
1999)S7
*
1-TDT (Sun et al.,
1999)S8
* *
Martin et al.
(1997)S9
* * *
George et al.
(1999)S10
* * * * *
P-TDT (Abecasis
et al., 2000)S11
* * * * *
Bickeboller and
Clerget-Darpoux
(1995)S12
*
Spielman and
Ewens (1996)S13
*
Purcell et al.
(2005)S14
* * *
TDT(max) (Morris,
1997)S15
*
Lazzeroni and
Lange (1998)S16
* *
Monks and Kaplan
(2000)S17
* * * *
Xiong et al.
(1998)S18
* *
Continued
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Table S1. Continued
Incorporation of:
Method/
Reference
Missing
parents
Multiple
alleles
Parental
phenotypes
Quantitative
traits
Extended
pedigrees
Different
family
structures
Multiple
markers
Covariates
Fan and Jung
(2002)S19
* * * *
TDT(Q1) –
TDT(Q5) (Allison,
1997)S20
* *
Rabinowitz
(1997)S21
* * *
Allison et al.
(1999)S22
* * *
Sun et al. (2000)S23 * * * *
Schaid and
Rowlands (2000)S24
* * *
Waldman et al.
(1999)S25
* *
Sinsheimer et al.
(2000)S26
* * * * *
Kistner and
Weinberg (2004)S27
* * *
QTDT (Abecasis
et al., 2000)S28
* * * *
Zhu and Elston
(2001)S29
* * * *
PDT (Martin,
2000)S30
* *
Goring and
Terwilliger
(2000)S31
* *
Clayton and Jones
(1999)S32
* *
ETDT (Sham and
Curtis, 1995)S33
*
TDT-EX (Cleves
et al., 1997)S34
* *
Fulker (1999)S35 * * *
Fan et al. (2002)S36 * * *
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